Mediviz Pharma Services Private Limited - Due diligence report

A 360° intelligence report on Mediviz Pharma Services Private Limited: trust score, financial health, credit view, compliance, directors, gr…

2013-11-28 Visakhapatnam, Andhra Pradesh Active Unlisted Active Compliant
Share
Connect MCP
MP Mediviz Pharma Services Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mediviz Pharma Services Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
91/100
Trust Score
Low Risk

Mediviz Pharma Services Private Limited is assessed as Low Risk with a Trust Score of 91/100. Mediviz Pharma Services Private Limited is an active private limited indian non-government company incorporated in 2013, operating in the Travel and Hospitality sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 13 Aug 2026 from the latest processed filings. Mediviz Pharma Services Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
91/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 5 open (11.48 cr) · 1 satisfied (42.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Sidbi5 48.0 cr
Andhra Pradesh State Financial Corporation1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VENKATA RAMA SATYA VANI MEDISETTY 01234567 Director 01/04/2018 6 yrs Approved
RAMBABU MEDISETTY 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: RAMBABU MEDISETTY (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
5 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment89/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 11.48 cr already registered.
  • Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
14 Feb 2025
Charge created
Sidbi - 4.55 cr
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Mar 2024
Charge created
Sidbi - 1.00 cr
02 Jan 2023
Securities allotted
200000 Equity Shares - 20.00 Lakh raised
30 Jun 2022
Charge created
Sidbi - 4.95 cr
01 Jul 2021
Charge created
Sidbi - 55.40 Lakh
03 May 2021
Charge satisfied
Andhra Pradesh State Financial Corporation
01 May 2021
Director ceased
RAMBABU MEDISETTY
11 Jan 2021
Charge created
Sidbi - 43.00 Lakh
12 May 2015
Securities allotted
200000.00 Equity Shares - 20.00 Lakh raised
06 Sep 2014
Charge created
Andhra Pradesh State Financial Corporation - 42.00 Lakh
28 Nov 2013
Incorporated
Registered with Roc Vijayawada
Director appointed
VENKATA RAMA SATYA VANI MEDISETTY (Director)
Director appointed
RAMBABU MEDISETTY (Managing Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Servsys Technology Services India Private Limited U72900KL2016PTC046910 Ernakulam, Kerala, India
Aw Solar Solutions India Private Limited U40106DL2015PTC287180 New Delhi, Delhi, India
Equinox Environments India Private Limited U90000PN2009PTC134168 Kolhapur, Maharashtra, India
Hi-Tech Thermal Insulations Private Limited U24100MH2009PTC190086 Navi Mumbai, Maharashtra, India
Webileapps U72300MH2011PTC430927 Mumbai, Maharashtra, India
Megdap U74900PN2013PTC148049 Pune, Maharashtra, India
Comcx It Private Limited U74999TG2018FTC125197 Hyderabad, Telangana, India
Bkc Weathersys U74140DL1998PTC095066 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Mediviz Pharma Services Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Mediviz Pharma Services Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Mediviz Pharma Services Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 91/100, distress signals and MSME payment-delay disclosures - know whether Mediviz Pharma Services Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mediviz Pharma Services Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Mediviz Pharma Services Private Limited an active company?

Mediviz Pharma Services Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Mediviz Pharma Services Private Limited financially healthy?

Mediviz Pharma Services Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Mediviz Pharma Services Private Limited?

Its overall Trust Score is 91/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Mediviz Pharma Services Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Mediviz Pharma Services Private Limited have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Mediviz Pharma Services Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Mediviz Pharma Services Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.